PTSD 4-Month Pre-Clinical Study Jan 26, 2021

Examining the Scientific Basis for a Novel Combination of Growth Factors and Neurotrophic Factors to Decrease Autonomic Over-expression and Rebalance Dysfunctional Cell-signaling Pathways to Attenuate Symptoms Associated with Posttraumatic Stress Disorder (PTSD) – a 4-month Pre-clinical Study

Coronavirus Infection Analysis

Research and Hypotheses behind Creating a Multifactorial Set of Three Coronavirus Relief Signaling Formulas
(Prophylactic, Symptomatic, Severe)
Exposure –Infection –Inflammation –Pneumonia –Pulmonary Failure –Mortality

Ann McCombs, DO, DNM
Functional Medicine, Holistic Medicine, Integrative Medicine